Skip to main content
Journal cover image

Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States.

Publication ,  Journal Article
Williams, JE; Trahanas, JM; Klapper, JA; Demarest, C; Lagisetty, KH; Chang, AC; Lyu, DM; Odell, DD; Bacchetta, MD; Williams, AM
Published in: Clin Transplant
March 2025

INTRODUCTION: Use of normothermic regional perfusion (NRP) to recover donation after circulatory death (DCD) organs demonstrates increased heart utilization with favorable outcomes. Conversely, DCD lung allograft use when NRP was employed remains controversial. This is a contemporary analysis of DCD lung recipient outcomes in which NRP was used. METHODS: Utilizing the STAR-OPTN database, all adult DCD lung recipients in the United States between January 1, 2020, and June 30, 2024 were identified. NRP use was defined if the time between donor death and aortic clamp time was greater than 30 min. Recipient outcomes, including 30-, 60-, and 90-day mortality, grade-3 primary graft dysfunction (PGD), and postoperative length of stay were compared using multivariable logistic regression controlling for donor and recipient covariates. Survival analysis was performed using Cox proportional hazard modeling. RESULTS: Of 987 DCD lung transplants, 92 (9.4%) utilized NRP. There were no differences in recipient characteristics between direct recovery and NRP cohorts. No difference in 30-, 60-, or 90-day mortality, grade-3 PGD, or length of stay was found between cohorts. 12-month survival was equivalent. CONCLUSIONS: Outcomes between NRP lung recipients were equivalent to DCD direct recovery recipients. Thus, donor lungs may be considered for transplantation following NRP donation procedures.

Duke Scholars

Published In

Clin Transplant

DOI

EISSN

1399-0012

Publication Date

March 2025

Volume

39

Issue

3

Start / End Page

e70135

Location

Denmark

Related Subject Headings

  • United States
  • Tissue and Organ Procurement
  • Tissue Donors
  • Survival Rate
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Perfusion
  • Organ Preservation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Williams, J. E., Trahanas, J. M., Klapper, J. A., Demarest, C., Lagisetty, K. H., Chang, A. C., … Williams, A. M. (2025). Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States. Clin Transplant, 39(3), e70135. https://doi.org/10.1111/ctr.70135
Williams, Jonathan E., John M. Trahanas, Jacob A. Klapper, Caitlin Demarest, Kiran H. Lagisetty, Andrew C. Chang, Dennis M. Lyu, David D. Odell, Matthew D. Bacchetta, and Aaron M. Williams. “Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States.Clin Transplant 39, no. 3 (March 2025): e70135. https://doi.org/10.1111/ctr.70135.
Williams JE, Trahanas JM, Klapper JA, Demarest C, Lagisetty KH, Chang AC, et al. Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States. Clin Transplant. 2025 Mar;39(3):e70135.
Williams, Jonathan E., et al. “Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States.Clin Transplant, vol. 39, no. 3, Mar. 2025, p. e70135. Pubmed, doi:10.1111/ctr.70135.
Williams JE, Trahanas JM, Klapper JA, Demarest C, Lagisetty KH, Chang AC, Lyu DM, Odell DD, Bacchetta MD, Williams AM. Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States. Clin Transplant. 2025 Mar;39(3):e70135.
Journal cover image

Published In

Clin Transplant

DOI

EISSN

1399-0012

Publication Date

March 2025

Volume

39

Issue

3

Start / End Page

e70135

Location

Denmark

Related Subject Headings

  • United States
  • Tissue and Organ Procurement
  • Tissue Donors
  • Survival Rate
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Perfusion
  • Organ Preservation